Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Abbosh

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2024
Reply to S. SorscherJames Hadfield, Chris Abbosh, Darren Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2024
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?Dan Stetson, Paul Labrousse, Hugh Russell, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
Trends in Cancer|June 5, 2024
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancerChris Abbosh, Darren Hodgson, Gary J Doherty, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 3, 2015
Breast Neoplasms with Dermal Analogue Differentiation (Mammary Cylindroma): Report of 3 Cases and a Proposal for a New TerminologyEmad A Rakha, Andrew H S Lee, Rachael Sheeran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2025
Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non-Small Cell Lung CancersArnaud Driussi, Fabien C Lamaze, Manal Kordahi, et al.
Cancer Letters|May 26, 2024
Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancerYohan Bossé, Abhijit Dasgupta, Michael Abadier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2025
Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancerTae Hee Hong, Soohyun Hwang, Chris Abbosh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2024
Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLCTae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2024
Reply to S. SorscherJames Hadfield, Chris Abbosh, Darren Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2024
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?Dan Stetson, Paul Labrousse, Hugh Russell, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
Trends in Cancer|June 5, 2024
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancerChris Abbosh, Darren Hodgson, Gary J Doherty, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 3, 2015
Breast Neoplasms with Dermal Analogue Differentiation (Mammary Cylindroma): Report of 3 Cases and a Proposal for a New TerminologyEmad A Rakha, Andrew H S Lee, Rachael Sheeran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2025
Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non-Small Cell Lung CancersArnaud Driussi, Fabien C Lamaze, Manal Kordahi, et al.
Cancer Letters|May 26, 2024
Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancerYohan Bossé, Abhijit Dasgupta, Michael Abadier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2025
Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancerTae Hee Hong, Soohyun Hwang, Chris Abbosh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2024
Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLCTae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Pageof 2